Application no. and date | 10179422.0 (espacenet) (Federated) (European Patent Register), 20051207 | Patent/reg. no. and date | DK/EP 2261236, 20150715 | Publication date | 20101215 | Priority no. and date | US 634366 P, 20041207, US 655930 P, 20050223 | EP pub. no. and date |
EP 2261236 20101215 | Effective date | | Applicant/owner | Onyx Therapeutics, Inc., One Amgen Center Drive Thousand Oaks, CA 91320-1799, US | Applicant ref. no. | P81504051DK00E | Inventor | LEWIS, Evan R., 631 Miller Avenue
Pacifica, CA 94044, US, HO, Mark Nguyen, 3330 Shoshana Lane
San Jose, CA 95135, US, FONSECA, Fabiana N., 30 River Road, Apt. 8g
New York, NY 10044, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 38/14 (2006.01) , C07K 5/087 (2006.01) | Title | Sammensætning til hæmning af proteasomet | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|